Survivin has potential as a biomarker for cancer diagnosis and prognosis. Its expression levels can be correlated with disease stage, tumor aggressiveness, and patient outcomes. Furthermore, detecting survivin in circulating tumor cells or serum samples could provide a non-invasive method for monitoring disease progression and treatment response.
